Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667824 | 0.82 | ALDH1A1 (0.41) | ALDH1A1CA1CA2KMT2AL3MBTL1 | |
| SCHEMBL7132233 | 0.80 | HDAC1 (0.47) | ALDH1A1CA1CA2KMT2AL3MBTL1 | |
| SCHEMBL1290930 | 0.80 | KMT2A (0.58) | ALDH1A1CA1CA2KMT2ASMN1; SMN2 | |
| SCHEMBL68148 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CA1CA2MAPTCES2 | |
| SCHEMBL20587670 | 0.79 | ALDH1A1 (0.59) | ALDH1A1CA1CA2MAPTCES2 | |
| SCHEMBL91167 | 0.78 | PRSS1 (0.48) | ALDH1A1CA1CA2KMT2ANPC1 | |
| SCHEMBL186794 | 0.78 | CA1 (0.64) | ALDH1A1CA1CA2KMT2AMEN1 | |
| SCHEMBL2998259 | 0.78 | ALDH1A1 (0.60) | ALDH1A1CA1CA2KMT2AMEN1 | |
| Methylene Chloride SCHEMBL29223376 | 0.76 | ALDH1A1 (0.52) | ALDH1A1CA1CA2L3MBTL1KDM4E | |
| SCHEMBL18892653 | 0.76 | ALDH1A1 (0.43) | ALDH1A1CA1CA2KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106132923-B | Oligoaniline derivative, charge-transporting varnish and organic electroluminescent device | 日产化学工业株式会社 | 2019-11-15 | — | — | CN | disclosed |
| CN-107210377-B | Varnish for forming charge-transporting thin film | 日产化学工业株式会社 | 2019-07-05 | — | — | CN | disclosed |
| CN-109983007-A | Amide derivatives inhibitor and its preparation method and application | 江苏豪森药业集团有限公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-109400625-A | Condensed-bicyclic class compound and its application in drug | 广东东阳光药业有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-107112428-B | Charge-transporting varnish and organic electroluminescent device | 日产化学工业株式会社 | 2019-01-22 | — | — | CN | disclosed |
| CN-108698982-A | FLUORINE ATOM-CONTAINING COMPOUND AND USE THEREOF | 日产化学工业株式会社 | 2018-10-23 | — | — | CN | disclosed |
| CN-107710440-A | Charge-transporting varnish and organic electroluminescent element | 日产化学工业株式会社 | 2018-02-16 | — | — | CN | disclosed |
| CN-102977029-B | As 5 HT2ASerotonin receptor modulator is applied to treat 3 phenylpyrazole derivatives of relative illness | 艾尼纳制药公司 | 2017-12-19 | — | — | CN | disclosed |
| US-9834542-B2 | LXR modulators | BRISTO-MYERS SQUIBB COMPANY (US) | 2017-12-05 | — | — | US | disclosed |
| EP-2968275-B1 | LXR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2017-11-29 | — | — | EP | disclosed |
| US-20040162325-A1 | Heterocyclic compounds | KUWABARA KENJI (JP) | 2004-08-19 | — | — | US | disclosed |
| US-20030166697-A1 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2003-09-04 | — | — | US | disclosed |
| WO-2003068828-A1 | SOLID CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS, CATALYST COMPRISING THE SAME AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2003-08-21 | — | — | WO | disclosed |
| WO-2003068723-A1 | POLYOL ESTER COMPOUNDS USEFUL IN PREPARATION OF A CATALYST FOR OLEFINS POLYMERIZATION, PROCESS FOR PREPARING THE SAME AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2003-08-21 | — | — | WO | disclosed |
| CN-1430612-A | Hete rocyclic derivatives | NIPPON SHINYAKU CO LTD (JP) | 2003-07-16 | — | — | CN | disclosed |
| EP-1295875-A1 | HETEROCYCLIC COMPOUNDS | Nippon Shinyaku Co., Ltd. (JP) | 2003-03-26 | — | — | EP | disclosed |
| EP-0789046-B1 | Polyamic acid, polyimide and liquid crystal aligning agent | JSR CORP (JP) | 1999-12-15 | — | — | EP | disclosed |
| US-5783656-A | REACTING AN AROMATIC DIAMINE WITH A TETRACARBOXYLIC DIANHYDRIDE | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1998-07-21 | — | — | US | disclosed |
| EP-0789046-A1 | Polyamic acid, polyimide and liquid crystal aligning agent | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
| US-4500471-A | REACTING TRICHLORO-OR TRIBROMOMETHYLBENZOYL HALIDES WITH HYDROGEN FLORIDE | OCCIDENTAL CHEMICAL CORPORATION (US) | 1985-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040162325-A1 | Heterocyclic compounds | LIPE, GPR119, LIPC | ALDH1A1 557/4885CA1 4533/4885CA2 3008/4885 |
| US-20030166697-A1 | Heterocyclic compounds | LIPE, GPR119, LIPC | ALDH1A1 557/4885CA1 4533/4885CA2 3008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.